Camex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2025 ,inter alia, to consider and approve 1. To consider and approve the Audited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Camex Ltd has informed BSE that its Board of Directors will meet on May 15, 2025 to consider and approve the audited financial results for the quarter and financial year ended March 31, 2025, along with the statutory auditor's report. The Board will also approve the financial statements for FY25. Additionally, Mr. Jagrit Sanklecha is being appointed as an Additional Director (Non-Executive Independent). The bulk of the agenda focuses on approving multiple Related Party Transactions (RPTs) for three-year periods (FY26-FY28), covering job work with Camex Industries (up to Rs 1.5 Cr p.a.), rent paid to the MD's family HUF (with 10% annual escalation), and purchase/sale arrangements with Creative Texchem (Rs 5 Cr p.a.), Camex Wellness (Rs 50 Lacs p.a.), and Camex Speciality (Rs 2 Cr p.a.). Salary payments to the wives/daughters of directors are also being approved. The Nomination and Remuneration Committee and Stakeholder Relationship Committee are being reconstituted. The trading window has been closed since April 1, 2025.
This is a routine pre-results board meeting notice with the main point of interest being the heavy volume of related party transactions being tabled for approval, including dealings between the company and entities connected to its promoter family. Investors should watch the actual FY25 audited numbers when released on May 15 for real performance signals; the RPTs largely represent business-as-usual arrangements with group entities spread over three years.